Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
30.0%
% of FTXH's 51 holdings also in PBE
53.6%
% of PBE's 28 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 3.6% | 4.8% | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.6% | 5.1% | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 3.5% | 4.9% | 3.5% |
|
GILEAD SCIENCES INC | 3.5% | 4.9% | 3.5% |
|
BIOGEN IDEC INC | 3.4% | 4.7% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PBE
|
BRISTOL-MYERS SQUIBB CO | 7.4% |
|
MERCK & CO. INC. | 7.4% |
|
PFIZER INC | 7.3% |
|
ABBVIE INC | 7.1% |
|
JOHNSON & JOHNSON | 6.9% |
|
ELI LILLY & CO | 3.8% |
|
CARDINAL HEALTH INC | 3.6% |
|
VIATRIS, INC. | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.1% |
|
ZOETIS INC | 3.1% |
FTXH Underweight Relative to PBE
|
BIO-TECHNE CORPORATION | -4.8% |
|
BIOMARIN PHARMACEUTICAL INC | -4.5% |
|
NEUROCRINE BIOSCIENCES INC | -4.5% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.5% |
|
CATALYST PHARMACEUTICAL PART | -3.1% |
|
PTC THERAPEUTICS INC | -2.9% |
|
VERICEL CORPORATION | -2.9% |
|
CELLDEX THERAPEUTICS INC | -2.9% |
|
DYNAVAX TECHNOLOGIES CORP | -2.7% |
|
TG THERAPEUTICS INC | -2.6% |